Genetic relationships and epidemiological links between wild type 1 poliovirus isolates in Pakistan and Afghanistan

Virology Journal

Syed Sohail Zahoor Zaidi¹  Adnan Khurshid¹  Salmaan Sharif¹  Muhammad M Alam¹  Shahzad Shaukat¹  Mehar Angez¹ 

[1] Virology Department, National Institute of Health Park Road, Chak Shahzad, Islamabad (45500), Pakistan

关键词: Molecular epidemiology;    Afghanistan;    Pakistan;    Wild type1;    Poliovirus;   

Others  :  1155005
DOI  :  10.1186/1743-422X-9-51

 received in 2011-06-25, accepted in 2012-02-22,  发布年份 2012

【 摘 要 】

Background/Aim

Efforts have been made to eliminate wild poliovirus transmission since 1988 when the World Health Organization began its global eradication campaign. Since then, the incidence of polio has decreased significantly. However, serotype 1 and serotype 3 still circulate endemically in Pakistan and Afghanistan. Both countries constitute a single epidemiologic block representing one of the three remaining major global reservoirs of poliovirus transmission. In this study we used genetic sequence data to investigate transmission links among viruses from diverse locations during 2005-2007.

Methods

In order to find the origins and routes of wild type 1 poliovirus circulation, polioviruses were isolated from faecal samples of Acute Flaccid Paralysis (AFP) patients. We used viral cultures, two intratypic differentiation methods PCR, ELISA to characterize as vaccine or wild type 1 and nucleic acid sequencing of entire VP1 region of poliovirus genome to determine the genetic relatedness.

Results

One hundred eleven wild type 1 poliovirus isolates were subjected to nucleotide sequencing for genetic variation study. Considering the 15% divergence of the sequences from Sabin 1, Phylogenetic analysis by MEGA software revealed that active inter and intra country transmission of many genetically distinct strains of wild poliovirus type 1 belonged to genotype SOAS which is indigenous in this region. By grouping wild type 1 polioviruses according to nucleotide sequence homology, three distinct clusters A, B and C were obtained with multiple chains of transmission together with some silent circulations represented by orphan lineages.

Conclusion

Our results emphasize that there was a persistent transmission of wild type1 polioviruses in Pakistan and Afghanistan during 2005-2007. The epidemiologic information provided by the sequence data can contribute to the formulation of better strategies for poliomyelitis control to those critical areas, associated with high risk population groups which include migrants, internally displaced people, and refugees. The implication of this study is to maintain high quality mass immunization with oral polio vaccine (OPV) in order to interrupt chains of virus transmission in both countries to endorse substantial progress in Eastern-Mediterranean region.

【 授权许可】

   
2012 Angez et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Global Polio Eradication Initiative [http://www.polioeradication.org/history.asp] webcite 2009.
• [2]Global Polio Eradication Initiative [http://www.polioeradication.org/casecount.asp] webcite 2009.
• [3]Centers for Disease Control and Prevention: Progress toward poliomyelitis Eradication--Pakistan and Afghanistan. MMWR 2008, 57(12):315-319.
• [4]CDC: Progress report toward poliomyelitis eradication Afghanistan and Pakistan, 2009. MMWR 2010, 59:268-272.
• [5]Global polio eradication initiative strategic plan 2009-2013 frame work document [http:/ / www.polioeradication.org/ content/ publications/ pilot strategic plan09-13 frame wor k.pdf] webciteGeneva: World Health Organization; 2009.
• [6]Obregon R, Chitnis K, Morry C, Feek W, Bates J, Galway M, Ogden E: Achieving polio eradication: a review of health communication evidence and lessons learned in India and Pakistan. Bull World Health Organ 2009, 87:624-630.
• [7]Poliomyelitis Eradication in the Eastern Mediterranean Region Progress Report 2007-2008: WHO-EM/POL/380/E/08.09/1500
• [8]Communication Strategies for Polio Eradication: Afghanistan polio communication review meeting. Kabul; 2007.
• [9]Perspectives from the Global Poliomyelitis Eradication Initiative: MMWR supplements 1999, 48(SU01):50-56.
• [10]Centers for Disease Control and Prevention: Progress toward interruption of wild poliovirus transmission-worldwide, January 2006-May 2007. Morbid Mortal Weekly Rep 2007, 56(27):682-685.
• [11]National emergency actionplan 2011 for polio eradication [http://www.polioeradication.org/Pakistan_National_emergency_plan.pdf] webciteFedral Ministry of health, Government of Islamic republic of Pakistan; 2011.
• [12]Ryan KJ, Ryan CG: Medical Microbiology (4th edition). In 2004. McGraw Hill; ISBN0838585299
• [13]Hogle J: Poliovirus cell entry: common structural themes in viral entry pathways. Annu Rev Microbiol 2002, 56:677-702.
• [14]Sabin AB, Boulger L: History of Sabin attenuated poliovirus oral live vaccinestrains. J Biol Stand 1973, 1:115-118.
• [15]Blondel B: Molecular aspects of poliovirus biology with a special focus on the interactions with nerve cells. J Neurovirol 1998, 4:1-26.
• [16]Wien MW, Chow M, Hogle JM: Poliovirus: new insights from an old paradigm. Structure 1996, 4:763-767.
• [17]Melnick JL: Current status of poliovius infections. Clin Microbiol Rev 1996, 9:293-300.
• [18]Shulman LM, Hansher R, Yang SJ, Yang CF, Manor J: Resolution of the pathways ofpoliovirus type 1 transmission during an outbreak. J Clin Microbiol 2000, 38:945-952.
• [19]Rolland RR: Piconaviridae and their replication. In Field Virology. 2nd edition. Edited by Fields BN, Knipe DM, et al. NY: Raven; 1990:507-605.
• [20]Holland JJ, de la Torre JC, Stemhawer DA: RNA virus population as quasispecies. Current Top Microbiol 1992, 176:1-20.
• [21]Jobra J, Campagnoli R, Kew O: Cliberation of multiple poliovirus molecular clocks covering an extended evolutionar range. J Virol 2008, 82(9):44429-44440.
• [22]Wimmer E, Hellen CU, Cao X: Genetics of poliovirus. Annu Rev Genet 1993, 27:353-436.
• [23]Adu FD: The virology of the polio virus. Ann Ibadan Postgraduate Med 2005, 39(1):13-19.
• [24]Rico-Hesse R, Pallansch MA, Nottay BK, Kew OM: Geographic distribution of wild poliovirus type 1 genotypes. Virology 1987, 160:311-322.
• [25]Kew OM, Mulders MN, Lipaskaya GY: Moleculaar epidemiology of poliovirus. Seminars in Virol 1995, 6:401-406.
• [26]Kew OM, Pallansch MA, Nottay BK, Rico-Hesse R, De L, Yang CF: Genomic relatiuonship among wild polioviruses from different regions of the world. In New aspects of positive strand RNA viruses. Edited by Brinton MA, Heinz FX. Washington DC: American Society for Microbiology; 1990:357-365.
• [27]WHO Manual for the virological investigation of poliomyelitis (WHO/EPI/CDS POLIO90.) Geneva; 1992.
• [28]Pipkin PA, Wood DJ, Racaniello VR, Minor PD: Characterization of L cells expressing the human poliovirus receptor for the specific detection polioviruses in vitro. J Virol Methods 1993, 41:333-340.
• [29]World Health Organization: Polio laboratory manual, 4th ed (WHO/IVB/04.10). Geneva: World Health Organization; 2004.
• [30]Yang CF, De L, Holloway BP, Pallansch MA, Kew OM: Detection and identification of vaccine related poliovirus by polemerase chain reaction. Virus Res 1991, 20:159-179.
• [31]van der Avoort HG, Hull BP, Hovi T, Pallansch MA, Kew OM, Crainic R, Wood DJ: Comparative study of five methods for intratypic differentiation of poliovirus. J Clin Microbiol 1995, 33:2562-2566.
• [32]Tamura K, Dudley J, Nei M, Kumar S: Phylogenetic and molecular evolutionary analyses were conducted using MEGA version 4. Mol Biol Evol 2007, 24:1596-1599.
• [33]Kimura M: A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980, 16:111-120.
• [34]Saitou N, Nei M: The neighbor-joining method: a new method for reconstructing Phylogenetic trees. Mol Biol Evol 1987, 4:406-425.
• [35]Sudhir K, Nei M, Dudley J, Tamaura K: MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences. Brief Bioinform 2008, 9(4):299-306.
• [36]World Health Organization: Expanding contributions of the global laboratory Network for poliomyelitis eradication, 2000-2001. Wkly Epidemiol Rec 2002, 77:133-137.
• [37]Lipskaya Yu G, Chervonskaya AE, Belova IG, Maslova VS, Kutateladze NT, Drozdov GS, Mulders M, Pallanch MA, Kew OM, Agol VI: Geographical genotypes (genotypes) of poliovirus case isolated from the former Soviet Union: relatedness to other known poliovirus genotypes. J Gen Virol 1995, 76:1687-1699.
• [38]Andrew JS, Jason AR, Carolyn LB, Hayden TP, Poh-Sien L, Bruce RT, John RD: Imported case of poliomyelitis, Melbourne, Australia. [http://www.cdc.gov/eid] webciteEmerging Infectious Diseases Publisher: Centers for Disease Control and Prevention; 2009, 15(1):63-65.
• [39]Huovilainen A, Mulder NM, Abotwalla M, Poyry T, Stenvik M, Hovi T: Genetic divergence of poliovirus strains isolated in the Karachi region of Pakistan. J Gen Virol 1995, 76:3079-3088.
• [40]Chezzi C, Nigel KB, Schoub BD: Molecular epidemiology of type 1 polioviruses from Africa. J Gen Virol 1997, 78:1017-1024.
• [41]Morvan JM, Chezzi C, Gouandjika I, Remerink JH, van der Avoort HG: Molecular epidemiology of type1 poliovirus in central African Republic. J Gen Virol 1997, 78:591-599.
• [42]Global Health Program [http://www.gatesfoundation.org/polio] webcite 2009.
• [43]Report on technical consultation on polio eradication in Afghanistan and Pakistan 2007. (Muscat1-2 Oct)
• [44]World Health Organization: Progress towards poliomyelitis eradication-Pakistan and Afghanistan. MMWR Wkly Epidemiol Rec 2008, 57(12):315-319.
• [45]Chumakov K, Ehrenfeld E, Wimmer E, Agol VI: Vaccine against polio should not be stopped. Nat Rev Microbiol 2007, 5(12):952-958.